Previous studies have shown that the acute blockade of STAT3 and STAT5 with SH-4-54, a small-molecule inhibitor targeting the SH2 domains of these two proteins, can increase xCT expression and thus improve system XC- activity in breast cancer cells. The gene discussed is STAT3; the disease is breast cancer.